Insomnia Interventions in Cancer Survivors

The purpose of this study is to evaluate two validated interventions for the treatment of
insomnia in cancer survivors of breast, colon, lung and prostate cancer. Moreover, it will
provide an opportunity to assess the efficacy of both of these interventions in a group
setting in patients of varied ethnic backgrounds including African-Americans, Latinos and
Caucasians. The results of this study will help clinicians provide future interventions
specific to cancer type and ethnicity in order to better serve the needs of our cancer
survivors and improve their quality of life.

Inclusion Criteria:

- signed informed consent

- age 18 and over

- diagnosis of breast, colon, lung, prostate or gynecologic cancer that is non
metastatic

- receiving treatment at one of the outpatient offices of the MD Anderson Cancer Center
at Cooper

- Self reported insomnia

- Not currently taking any medications to treat insomnia

- No medical or psychological condition that would prevent successful protocol
completion in the opinion of investigator.